Interleukin Genetics Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Interleukin Genetics Inc.
Deals Shaping the Medical Industry, September 2016
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.
Execs On The Move, September 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Medtech Execs On The Move, April 2016
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
FDA Warns DTC Genetic Test Firms
The warning letters are the first FDA sent since it carved out a de novo risk category for DTC carrier screening tests, clearing the path for 23andMe Inc. to relaunch its Personal Genome Service in October.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.